ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 725671 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 725671; 2) Community: the network communities that were significantly associated with the response to NSC 725671; 3) Molecule: the relationships between components within communities and NSC 725671; 4) MDR: the compounds that were significantly associated with the NSC 725671.

NSC Compound Enrichment Correlation
NSC 755880 Mitomycin (USAN) 0.00503396694999381 0.55268716
NSC 762346 Null 0.00503396694999381 0.34154946
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.00550789647802199 0.36382619
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.00550789647802199 -0.10999865
NSC 629868 Null 0.00550789647802199 -0.3783107
NSC 662784 Null 0.00550789647802199 0.093376884
NSC 381867 BAFILOMYCIN ANTIBIOTIC 0.00559873245069072 0.24323968
NSC 622579 Carbamimidothioic acid, N,N-dimethyl-N'-[(phenylimino) (methylthio)methyl]-, phenylmethyl ester, hydroiodide 0.00559873245069072 0.35096992
NSC 682436 Naphth[2,3-d]oxazol-9(4H)-one, 4-[(2-aminocyclohexyl) imino]-2-methyl-, acetate 0.00559873245069072 0.05484948
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.00578566967432525 -0.38649907
Total:71  Current:10    [First] [Prev] [Next] [Last]